Medical Journals

Regulation of the Expression of Soluble Guanylyl Cyclase by Reactive Oxygen Species.

Authors:
  • Gerassimou C
  • Kotanidou A
  • Zhou Z
  • Simoes D C M
  • Roussos C
  • Papapetropoulos A

From: Department of Critical Care and Pulmonary Services, G.P. Livanos-M. Simou Laboratories, University of Athens, Evangelismos Hospital, Athens, Greece.

British journal of pharmacology

  • Publish Date: Apr 2007
  • ISSN: 0007-1188
  • Volume: 150
  • Issue: 8
  • Pages: 1084-91
  • Medium: Print
  • Language: English
  • Citation (JAMA): Gerassimou C, Kotanidou A, Zhou Z, et al. Regulation of the Expression of Soluble Guanylyl Cyclase by Reactive Oxygen Species.. Br. J. Pharmacol. Apr 2007;150:1084-91

Abstract

BACKGROUND AND PURPOSE: Superoxide anions produced during vascular disease scavenge nitric oxide (NO), thereby reducing its biological activity. The aim of the present study was to investigate whether reactive oxygen species (ROS) have a direct effect on soluble guanylyl cyclase (sGC) subunit levels and function and to ascertain the mechanism(s) involved. EXPERIMENTAL APPROACH: Rat aortic smooth muscle cells (RASM) or freshly isolated vessels were exposed to reactive oxygen species (ROS)-generating agents and sGC subunit expression was determined at the mRNA and/or protein level. cGMP accumulation was also determined in RASM exposed to ROS. KEY RESULTS: Incubation of smooth muscle cells with H(2)O(2), xanthine/xanthine oxidase (X/XO) or menadione sodium bisulphite (MSB) significantly decreased protein levels of alpha1 and beta1 subunits of sGC and reduced SNP-induced cGMP formation. Similarly, sGC expression was reduced in freshly isolated vessels exposed to ROS-generating agents. The ROS-triggered inhibition of alpha1 and beta1 levels was not blocked by proteasome inhibitors, suggesting that decreased sGC protein was not due to protein degradation through this pathway. Real time RT-PCR analysis demonstrated a 68% reduction in steady state mRNA levels for the alpha1 subunit following exposure to H(2)O(2). In addition, alpha1 promoter-driven luciferase activity in RASM decreased by 60% after H(2)O(2) treatment. CONCLUSION AND IMPLICATIONS: We conclude that oxidative stress triggers a decrease in sGC expression and activity that results from reduced sGC steady state mRNA levels. Altered sGC expression is expected to contribute to the changes in vascular tone and remodeling observed in diseases associated with ROS overproduction.

Mesh Headings (Keywords): Animals, Aorta, Cells, Cultured, Cyclic GMP, Dose-Response Relationship, Drug, Gene Expression Regulation, Enzymologic, Guanylate Cyclase, Hydrogen Peroxide, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Nitric Oxide Donors, Nitroprusside, Oxidative Stress, Protein Subunits, RNA Stability, RNA, Messenger, Rats, Reactive Oxygen Species, Receptors, Cytoplasmic and Nuclear, Tissue Culture Techniques, Transcription, Genetic, Vitamin K 3, Xanthine, Xanthine Oxidase


Check for Full Text / PubMed Unique Identifier (PMID): 17339839


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.